JDVRX
Price
$23.86
Change
-$0.10 (-0.42%)
Updated
Aug 15 closing price
Net Assets
658.19M
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

JDVRX vs VVIAX

Header iconJDVRX vs VVIAX Comparison
Open Charts JDVRX vs VVIAXBanner chart's image
PGIM Jennison Value R
Price$23.86
Change-$0.10 (-0.42%)
VolumeN/A
Net Assets658.19M
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
JDVRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVRX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. JDVRX (658M). VVIAX pays higher dividends than JDVRX: VVIAX (2.18) vs JDVRX (1.30). JDVRX was incepted earlier than VVIAX: JDVRX (20 years) vs VVIAX (25 years). JDVRX (1.49) is less costly to investors than VVIAX (0.05). JDVRX is a more actively managed with annual turnover of: 29.00 vs. VVIAX (9.00). JDVRX has a lower initial minimum investment than VVIAX: JDVRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. JDVRX (6.34). VVIAX return over 5 years is better than : 68.54 vs. JDVRX (42.49).
JDVRXVVIAXJDVRX / VVIAX
Total Expense Ratio1.200.052,400%
Annual Report Gross Expense Ratio1.490.052,980%
Fund Existence20 years25 years-
Gain YTD7.3326.517113%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets658M196B0%
Annual Yield % from dividends1.302.1860%
Returns for 1 year6.347.9180%
Returns for 3 years16.8625.9365%
Returns for 5 years42.4968.5462%
Returns for 10 years22.84114.6120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp